Microtubules have been proposed to function as rigid struts which oppose cellular contraction. Consistent with this hypothesis, microtubule disruption strengthens the contractile force exerted by many cell types. We have investigated an alternative explanation for the mechanical effects of microtubule disruption: that microtubules modulate the mechanochemical activity of myosin by influencing phosphorylation of the myosin regulatory light chain (LC2o). We measured the force produced by a population of fibroblasts within a collagen lattice attached to an isometric force transducer. Treatment of cells with nocodazole, an inhibitor of microtubule polymerization, stimulated an isometric contraction that reached its peak level within 30 min and was typically 30-45% of the force increase following maximal stimulation with 30%o fetal bovine serum. The contraction following nocodazole treatment was associated with a 2-to 4-fold increase in LC2. phosphorylation. The increases in both force and LC20 phosphorylation, after addition of nocodazole, could be blocked or reversed by stabilizing the microtubules with paclitaxel (former generic name, taxol). Increasing force and LC20 phosphorylation by pretreatment with fetal bovine serum decreased the subsequent additional contraction upon microtubule disruption, a finding that appears inconsistent with a load-shifting mechanism. Our results suggest that phosphorylation of LC20 is a common mechanism for the contractions stimulated both by microtubule poisons and receptor-mediated agonists. The modulation of myosin activity by alterations in microtubule assembly may coordinate the physiological functions of these cytoskeletal components.
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Microtubule disruption induces a contraction in a strikingly diverse variety of tissue culture cells (1) (2) (3) (4) . The "force counterbalance" or "tensegrity" model of cytoskeletal structure explains this contraction as a transfer of contractile load from internal struts (microtubules) to sites of extracellular anchorage (5, 6 ). The tensegrity model provides a simple and elegant explanation for the mechanical effects of microtubule inhibitors that is consistent with many experimental observations. Nevertheless, measurements of the micromechanical loads upon specific cytoskeletal components of intact cells have not yet been achieved (7) , and so direct experimental verification of this model is not presently possible.
An obvious alternative to the tensegrity model, that microtubule disruption increases tension through activation of cellular contractile elements, has received less attention. Microtubules or microtubule-associated proteins may influence the dynamic properties of the actin cytoskeleton. Microtubule depolymerization can block or reverse the disruption of actin stress fibers by phorbol ester (1, 8) . Proteins have been identified that bind to both microtubules and actin filaments (9) (10) (11) (12) . It has been suggested (1) that depolymerization of microtubules may release associated proteins that organize actin filaments (12, 13) , possibly resulting in increased tension.
Microtubules may directly interact with intracellular signaling pathways. For example, disruption of microtubules can enhance transduction of signals mediated by GTP-binding proteins (14) or activate cellular protein kinases (15) . In addition, some protein kinases physically associate with microtubules (16) (17) (18) . Thus, microtubule disruption might initiate biochemical signals which activate the force-generating components of the cytoskeleton. This activation could be sufficient to account for both increased tension (19) and changes in actin organization (20) .
The major force-generating system of fibroblasts is composed of a cytoplasmic network of actin and myosin. Nonmuscle cells regulate actin-myosin interactions through reversible phosphorylation of the myosin regulatory light chain (LC20) (19, (21) (22) (23) (24) (25) , a mechanism analogous to the regulation of smooth muscle contraction. Thus, we can test the hypothesis that the mechanical consequences of microtubule disruption are mediated through activation of cytoplasmic myosin motor activity by correlating LC20 phosphorylation levels with isometric force.
We have previously described a technique designed to measure the tension exerted by fibroblasts cultured in a collagen matrix (19, 26) and have used this approach to demonstrate that microtubule disruption results in a 2-to 3-fold increase in force. This contraction is of similar magni- tude to that following stimulation with thrombin, a mitogen known to produce large intracellular free Ca2+ transients (26) . We subsequently established a correlation between isometric tension and LC20 phosphorylation in thrombin-stimulated chick embryo fibroblasts (CEFs) analogous to that documented in smooth muscle (19) .
In this report, we explore the possibility that microtubules regulate contraction by controlling the mechanochemical activity of myosin through phosphorylation of LC20. In addition, we quantitatively study the interactions between contraction stimulated by microtubule disruption and contraction stimulated through receptor-mediated agonists. Proc. Natl. Acad. Sci. USA 92 (1995) 10253 ing). The rods were separated by spacers and placed in rectangular wells (1.5 cm x 1.6 cm). Nine hundred eighty microliters of ice-cold DMEM/10% FBS containing CEFs at 0.9 x 106 cells per ml and rat tail collagen (Upstate Biotechnology, Lake Placid, NY) at 1.0-1.2 mg/ml was poured between the rods. The medium bathing the cells was replaced with serum-free DMEM 24 hr after the gels were cast.
MATERIALS AND METHODS
After 24-48 hr in serum-free medium, the preparation was mounted on the force transducer (19) Glycerol/urea/PAGE with immunoblotting was carried out by a modification of the procedure of Taylor and Stull (28) as described (19) or, in later experiments, the signal was enhanced with the following modifications. Protein was transferred to nitrocellulose in 23 mM glycine/20 mM Tris, pH 8.8/20% methanol. After transfer, the nitrocellulose membrane was incubated with 1% glutaraldehyde in phosphatebuffered saline for 5 min, washed three times in phosphatebuffered saline, and rinsed twice for 1 min with 0.1% NaBH4. The membrane with then blocked overnight at room temperature with 5% nonfat dry milk. LC20 was detected with a 1:1000 dilution of an affinity-purified rabbit antibody (a gift of Primal de Lannerole, University of Illinois) followed by ECL reagents (Amersham).
RESULTS
Contractility Is Coupled to Microtubule Disruption and Assembly. We measured the increase in the contractile force exerted by CEFs in fibroblast-populated collagen lattices (FPCLs) upon disruption of microtubules. Contraction was often apparent within seconds after addition of nocodazole (Fig. 1A) . Force typically increased 1-2 mN before reaching a steady level within about 30 min.
Treatment of cells with paclitaxel (former generic name, taxol) stabilizes microtubules to subsequent disruption by nocodazole (1, 29) . Pretreatment of CEFs with paclitaxel, 20 min prior to the addition of nocodazole, stabilizes microtubules to disruption (demonstrated by immunofluorescence, data not shown). Thus, paclitaxel-treated cells provide a control for any side effects of nocodazole which do not result from microtubule disruption.
Paclitaxel (10 ptM) entirely inhibited the nocodazoleinduced contraction ( Fig. 1 B and C) . The ability of paclitaxel to block contraction was specific for microtubule-disrupting agents, since contractions stimulated by thrombin (Fig. 1B) or 5% FBS (Fig. 1C) were not blocked in paclitaxel-treated cells.
Paclitaxel Reverses the Nocodazole-Induced Contraction. Because paclitaxel reverses microtubule disruption in nocodazole-treated cells, even in the continued presence of nocodazole (29), we tested the mechanical effect of adding paclitaxel to cells precontracted with nocodazole. Paclitaxel (in the continuous presence of nocodazole) stimulated a strikingly rapid relaxation ( Fig. 2A) . Force was reduced to its prenocodazole level within 5 min of paclitaxel addition and then typically declined an additional 200-300 ,uN at a slower rate. Cells relaxed in this manner still retained the ability to contract in response to thrombin (Fig. 2,4) . The rapid relaxation after paclitaxel was specific for nocodazole-contracted cells, since paclitaxel showed little effect on cells contracted with thrombin or FBS (Fig. 2 B and C) .
Time Course of Nocodazole-and FBS-Stimulated Contractions. Force increased rapidly in the first few minutes following addition of FBS and continued to increase at a slower rate throughout the entire 2-hr monitoring period (Fig. 3) . The contraction in response to nocodazole reached a maximum at about 30 min before declining slowly to 80% of its maximal value at 2 hr (Fig. 3) .
Microtubule Disruption Is Associated with Increased LC20 Phosphorylation. By measuring changes in LC20 phosphorylation following the addition of nocodazole, we investigated the possibility that microtubule disruption causes contraction through myosin activation. We found relatively large variations in baseline LC20 phosphorylation between different preparations of CEFs. Nevertheless, LC20 phosphorylation levels both before and after stimulation with nocodazole, thrombin, or FBS were consistent among different samples from the same preparation of CEFs. In agreement with our previous findings (19) , serum-starved CEFs typically had 10-40% of LC20 monophosphorylated with the remainder unphosphorylated. which continued for at least 40 min after stimulation (Fig. 4) . LC20 phosphorylation following nocodazole treatment was typically about equally divided between the mono-and diphosphorylated forms, although some experiments showed a significant preference toward the monophosphorylated form.
The LC20 phosphorylation after nocodazole was blocked by paclitaxel pretreatment or reversed by paclitaxel posttreatment (Fig. 5 ). Cells treated with 5 ,uM min followed by 10 ,uM paclitaxel for 20 min (without washout of nocodazole) or cells pretreated with 10 ,tM paclitaxel for 20 min before addition of 5 ,tM nocodazole for 20 min (without washout of paclitaxel) typically had LC20 phosphorylation levels below that of controls treated only with vehicle (dimethyl sulfoxide). This reduction in LC20 phosphorylation to below baseline levels was consistent with the corresponding force measurements ( Fig. 1 B and C and Fig. 2A) (Fig. 3) . Thus, the incremental effect of nocodazole was easiest to observe during this plateau in the FBS-stimulated contraction.
Force was measured over 110 min during which matched samples were treated either with 30% FBS for 80 min before addition of 10 ,uM nocodazole or with 10 ,tM nocodazole for 30 min before addition of 30% FBS. Total force was similar at the end of both protocols (Fig. 6) . However, the response to nocodazole in cells precontracted with FBS was only 32% of the nocodazole response from cells not precontracted with FBS. The effect of FBS precontraction on the nocodazole response is actually underestimated in this experiment, since the FBS response contributes to some of the force rise after the addition of nocodazole (Fig. 3) . Cells pretreated with nocodazole exhibited only 78% of the contractile response to FBS relative to cells with intact microtubules (Fig. 6) .
We were concerned that the large stress of 30% FBS contraction might somehow cause mechanical damage to the preparation which could result in the reduced additional response to nocodazole. Therefore, we measured the contractile response to microtubule disruption in single preparations both before and after washout of FBS. In a representative example (Fig. 7) , cells precontracted for 80 min with FBS generated an additional 780 ,uN after addition of nocodazole. However, after all agonists were washed out, a contraction of 1470 ,uN was measured in response to nocodazole. In four similar experiments, the nocodazole response after FBS was only 51 5% of that after washout.
Increasing Phosphorylation with FBS Decreases the Additional Phosphorylation from Nocodazole. We sought to -determine whether the decreased nocodazole-induced contraction of FBS-contracted cells was associated with a similarly blunted increase in LC20 phosphorylation. Cells showed a similar increase in LC20 phosphorylation after treatment with nocodazole (30 min) or FBS (80 or 120 min) (Fig. 8) . The additional change in LC20 phosphorylation following microtubule disruption of FBS-contracted cells was small to insignificant. Thus, preactivation with FBS results in an even more blunted effect on the LC20 phosphorylation response to microtubule disruption than on the corresponding force change.
DISCUSSION
Nocodazole Induces Contraction Through Microtubule Disruption. It appears highly unlikely that nocodazole stimulates contraction through a side effect rather than through microtubule disruption. Danowski (1) has shown that several microtubule inhibitors, all at very low concentrations, produce contractions of similar magnitude and that stabilization of microtubules with paclitaxel blocks the contractile activity of microtubule inhibitors. In Fig. 1 , we demonstrate that paclitaxel pretreatment blocked the contractile effects of nocodazole but did not block contraction stimulated by FBS or thrombin. Therefore, paclitaxel blocked the nocodazole con- traction specifically by stabilizing microtubules to nocodazole rather than by acting as a general inhibitor of contractility. The rapid reversal of contraction following repolymerization of microtubules by paclitaxel argues against a role for secretory products in mediating the nocodazole-stimulated contraction.
Mechanism of Contraction Resulting from Microtubule Disruption. The load-shifting and LC20 phosphorylation mechanisms predict opposite effects of preexisting myosin activation on nocodazole-stimulated contraction. If the force increase measured after nocodazole treatment was caused by contractile load shifting from microtubule struts to extracellular contacts, then increasing contractility by phosphorylating LC2o should increase the force that could be shifted off microtubules. If, however, the contraction resulting from microtubule disruption was due to LC20 phosphorylation, a prior contraction due to an increase in LC20 phosphorylation might saturate this response, resulting in a reduced additional contraction.
To determine the effect of preexisting LC20 phosphorylation on the magnitude of nocodazole-stimulated contraction, we used FBS to raise force and LC20 phosphorylation levels prior to addition of nocodazole. Cells precontracted with FBS showed a decreased contractile response to microtubule disruption. This result is inconsistent with the predictions of the tensegrity model but is consistent with microtubule disruption mediating contraction through an increase in LC20 phosphorylation. Furthermore, we found that nocodazole stimulated no further increase in LC20 phosphorylation of FBS-contracted cells, confirming that a component of the pathway leading to LC20 phosphorylation, utilized by both nocodazole and FBS, is saturated after FBS stimulation.
The similar increases in LC20 phosphorylation after treatment with 30% FBS for 80 min or 10 pLM nocodazole for 30 min (Fig. 8) were unexpected because 30% FBS stimulates a 2-to 3-fold larger force increase than nocodazole. Also surprising was that the small additional contractile response to microtubule disruption in FBS-contracted cells was not associated with a measurable increase in LC20 phosphorylation. The interpretation of these differences between the changes in force relative to LC20 phosphorylation in FBS and nocodazolestimulated contractions is complicated because the force and phosphorylation measurements were conducted on different preparations (FPCL vs. monolayer) and because of the possibility of a transient component to the LC20 phosphorylation increase following FBS stimulation (24) . However, these apparent differences between the dynamics of LC20 phosphorylation and force suggest that LC20 phosphorylation may not be the only mechanism mediating the FBS-and nocodazolestimulated contractions.
Microtubule Dynamics Are Coupled to LC20 Phosphorylation. The central finding of this work is the coupling of microtubule dynamics to LC20 phosphorylation. Although the physiological significance of this link between microtubule and microfilament dynamics is unknown, our findings are consistent with the hypothesis that microtubules organize motile functions of nonmuscle cells. In contrast to muscle cells, which are specialized for unaxial contraction, nonmuscle cells exhibit more complex motile activity. Cell locomotion and cell division involve contractions confined to specific regions of the cell (30, 31) . Therefore, these functions are likely to utilize mechanisms that modulate myosin activity in specific regions of the cytoplasm.
Spatially inhomogeneous shifts in microtubule morphology or stability precede directed cell locomotion and cell division (31) (32) (33) (34) , suggesting that microtubules may direct the subcellular distribution of the forces driving these processes. The present results support a role for myosin activation, through LC20 phosphorylation, as a mechanism by which microtubules might direct the spatial pattern of contractility within cells.
Summary. Our purpose was to better define how microtubule disruption leads to cell contraction. Although our results do not rule out a contribution from a tensegrity mechanism, increased LC20 phosphorylation following microtubule disruption suggests that myosin activation may partially or fully explain the contractile and morphological effects of microtubule disruption. The interactions between microtubules and intracellular free Ca2+ regulation or other pathways leading to LC20 phosphorylation (28) remain an important question.
